BBIXF Dividend: Bonus Biogroup Ltd Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

BBIXF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	10	9	10	14	43	8
Research & Development	14	15	16	19	19	10
Operating Expenses	24	27	29	37	64	19
Other Non Operating Income (Expenses)	--	0	0	0	-24	-1
Pretax Income	-25	-27	-28	-38	-90	-22
Income Tax Expense	--	--	--	--	--	--
Net Income	-25	-27	-28	-38	-90	-22
Net Income Growth	-14%	-4%	-26%	-57.99%	309%	0%
Shares Outstanding (Diluted)	633.4	624.42	570.58	1,167.92	1,154.05	998.98
Shares Change (YoY)	-10%	9%	-51%	1%	16%	19%
EPS (Diluted)	-0.03	-0.04	-0.05	-0.03	-0.07	-0.02
EPS Growth	-8%	-11%	51%	-57.99%	254.99%	-17%
Free Cash Flow	-18	-21	-27	-35	-45	-16
Free Cash Flow Per Share	-0.02	-0.03	-0.04	-0.02	-0.03	-0.01
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-22	-25	-27	-35	-63	-18
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	2	2	2	2	1	1
EBIT	-24	-27	-29	-37	-64	-19
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--